InvestorsHub Logo
Followers 97
Posts 4817
Boards Moderated 0
Alias Born 02/07/2021

Re: ATLnsider post# 600786

Monday, 06/12/2023 5:23:43 PM

Monday, June 12, 2023 5:23:43 PM

Post# of 702038
Yes, Rindopepimut looked great in Phase II then it failed in Phase III.

DCVax will own the GBM market with first mover advantage backed by the best approach to attack heterogeneous tumors.

Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News